MARKET

INSM

INSM

Insmed Inc
NASDAQ
19.03
+0.34
+1.82%
Closed 17:00 05/31 EDT
OPEN
18.77
PREV CLOSE
18.69
HIGH
19.20
LOW
18.63
VOLUME
766.34K
TURNOVER
--
52 WEEK HIGH
28.94
52 WEEK LOW
16.04
MARKET CAP
2.60B
P/E (TTM)
-4.4642
1D
5D
1M
3M
1Y
5Y
Insmed Inc: Statement of changes in beneficial ownership of securities
Press release · 5d ago
Insmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conference
PR Newswire · 05/22 20:05
Insmed Inc: Report of proposed sale of securities
Press release · 05/20 20:23
Insmed Inc: Securities to be offered to employees in employee benefit plans
Press release · 05/19 16:23
About INSM
Insmed Incorporated is a biopharmaceutical company. It is engaged in providing ARIKAYCE (amikacin liposome inhalation suspension) product, which is used for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its clinical-stage pipeline includes brensocatib and treprostinil palmitil inhalation powder (TPIP). Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1, which is developed for the treatment of patients with bronchiectasis, cystic fibrosis (CF) and other neutrophil-mediated diseases, including chronic rhinosinusitis without nasal polyps (CRS) and hidradenitis suppurativa (HS). TPIP is an inhaled formulation of the treprostinil prodrug treprostinil palmitil which offers a differentiated product profile for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Webull offers kinds of Insmed Incorporated stock information, including NASDAQ:INSM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INSM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading INSM stock methods without spending real money on the virtual paper trading platform.